Gene expression profiling predicts pathways and genes associated with Parkinson's disease

Area of Science:

• Neuroscience
• Genomics
• Bioinformatics

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder.
• Understanding the molecular mechanisms of PD is critical for developing effective treatments.

Purpose of the Study:

• To explore the molecular mechanisms underlying Parkinson's disease (PD) development.
• To identify key pathways and genes associated with PD pathogenesis.

Main Methods:

• Downloaded and analyzed microarray data (GSE22491) from PD patients and healthy controls (HC).
• Identified differentially expressed genes (DEGs) using paired t-test.
• Performed cluster analysis, principal component analysis, Gene Ontology (GO) and pathway enrichment analyses, and constructed protein-protein interaction (PPI) networks.

Main Results:

• Identified 176 up-regulated and 49 down-regulated DEGs.
• Found 39 GO terms and 72 pathways significantly related to PD.
• The neuronal system pathway was enriched by 10 DEGs, including synapsin I (SYN1), glutamate receptor, ionotropic, N-methyl-D-aspartate 1 (GRIN1), and GRIN2D.
• Identified 18 hub genes in PPI networks, such as GRIN2D and discs, large (Drosophila) homolog-associated protein 3 (DLGAP3).

Conclusions:

• The neuronal system pathway and its enriched DEGs play significant roles in PD progression.
• DEGs such as SYN1, GRIN1, GRIN2D, and DLGAP3 are promising candidate genes for PD.
• These findings contribute to understanding PD molecular mechanisms and may aid in developing diagnostic and therapeutic strategies.